DAIC

FEBRUARY 14, 2024

Using multiple, serial, intravascular scaffolds, the patented FlexStep Technology combines flexibility with support to open clogged vessels and sustain healthy blood flow while accommodating tortuosity and skeletal movement.

Heart attacks 111

Heart attacks Heart Attack Peripheral Arterial Disease Ischemia 111

DAIC

MARCH 1, 2024

Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. Boston Scientific plans to launch the technology in the U.S.

Stent 105

Stent Stents Coronary Artery Disease Angioplasty 105

DAIC

MAY 3, 2024

Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol and Weight Using Mobile Technology 2. Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable 9.

Angioplasty 105

Angioplasty Blood Pressure Heart attacks Heart Attack 105

DAIC

MARCH 13, 2024

In an original investigation presented at the Cardiology Research Technology conference in Washington, D.C. suggest that the drug-coated balloon offers an effective treatment strategy for the management of coronary in-stent restenosis, or blockages recurring within previously placed stents.

Stents 116

Stents Stent Angioplasty Myocardial Infarction 116

DAIC

FEBRUARY 24, 2025

AI-enabled remote cardiac monitoring is is already revolutionizing how we detect, diagnose, mitigate and manage heart conditions. By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable.

Hospital 52

Hospital Cardiovascular Disease Heart Failure Heart attacks 52

DAIC

MAY 14, 2024

The collaboration seeks to provide access to emerging technologies, like Medis QFR, while also reducing complexity in the cath lab to improve the operating environment for clinicians. This analysis can be performed in real time while the patient is on the table and results are displayed on the large display monitor in the cath lab.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

APRIL 5, 2024

Shockwave is a leading, first-to-market provider of innovative intravascular lithotripsy (IVL) technology for the treatment of calcified CAD and PAD. IVL is a minimally invasive, catheter-based treatment for calcified arterial lesions, which can reduce blood flow and cause pain or heart attack.

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105